Overview
- Editors:
-
-
Abel Lajtha
-
Neurochemistry and Drug Addiction, New York State Research Institute, New York, USA
Access this book
Other ways to access
Table of contents (21 chapters)
-
Front Matter
Pages i-xxiii
-
-
-
-
-
-
-
- Kunihiko Suzuki, Kinuko Suzuki
Pages 131-142
-
- Hobart E. Wiltse, John H. Menkes
Pages 143-167
-
-
-
-
-
-
- Helen H. Hess, Alfred Pope
Pages 289-327
-
- Larry J. Embree, Norman H. Bass, Alfred Pope
Pages 329-369
-
-
-
-
About this book
Anyone who has any contact with mental patients, old or young, or their families, or just visits a mental hospital or school for the retarded, is aware of the tremendous suffering caused by malfunctioning of the brain. The func tion of no other organ is so crucial for our everyday life, our proper func tioning, indeed our happiness, and no other illness causes as much anguish to patients or their families as mental illness. It is surprising and sad, therefore, how little effort has been devoted to research in this area; more so because such research is the only hope to ameliorate this suffering, or, to speak in the language of politics or economics, to decrease the enormous sums that we spend on trying to help our patients, with what is must generally be agreed are the most primitive and inadequate methods of treatment. Clearly, since functions of the brain are vital not only in illness, but in health, pathology is not the only area of concern to neurochemists, but it is an area that urgently needs neurochemical contributions. Progress in this field has been slower than in other areas of neurochemistry, and it seems that solutions in this field are very elusive. The reason for this is that the experimental approach is especially difficult in conditions specific for humans, or specific for complex behavior.
Editors and Affiliations
-
Neurochemistry and Drug Addiction, New York State Research Institute, New York, USA
Abel Lajtha
